Axon Enterprise, Inc. (NASDAQ:AXON) Shares Bought by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. raised its position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 4.6% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 449,507 shares of the biotechnology company's stock after acquiring an additional 19,818 shares during the period. Charles Schwab Investment Management Inc. owned approximately 0.59% of Axon Enterprise worth $267,151,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Asset Dedication LLC lifted its position in Axon Enterprise by 11.3% in the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company's stock valued at $106,000 after purchasing an additional 18 shares during the period. Bleakley Financial Group LLC raised its stake in shares of Axon Enterprise by 1.3% during the 4th quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company's stock worth $908,000 after buying an additional 20 shares in the last quarter. Venturi Wealth Management LLC lifted its holdings in shares of Axon Enterprise by 2.7% in the 4th quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company's stock valued at $477,000 after buying an additional 21 shares during the period. Insigneo Advisory Services LLC boosted its stake in shares of Axon Enterprise by 1.4% in the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company's stock valued at $627,000 after buying an additional 22 shares in the last quarter. Finally, Menard Financial Group LLC grew its holdings in Axon Enterprise by 0.8% during the third quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company's stock worth $1,204,000 after acquiring an additional 24 shares during the period. Hedge funds and other institutional investors own 79.08% of the company's stock.

Remove Ads

Axon Enterprise Price Performance

Axon Enterprise stock traded up $27.09 during midday trading on Friday, reaching $526.40. 1,277,703 shares of the company were exchanged, compared to its average volume of 853,402. The company has a market capitalization of $40.14 billion, a price-to-earnings ratio of 136.02, a P/E/G ratio of 5.17 and a beta of 1.12. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The firm's 50-day simple moving average is $599.42 and its 200-day simple moving average is $529.53. Axon Enterprise, Inc. has a 1 year low of $273.52 and a 1 year high of $715.99.

Insider Transactions at Axon Enterprise

In related news, insider Jeffrey C. Kunins sold 1,035 shares of the stock in a transaction dated Monday, December 23rd. The stock was sold at an average price of $624.47, for a total transaction of $646,326.45. Following the transaction, the insider now directly owns 124,243 shares in the company, valued at approximately $77,586,026.21. This represents a 0.83 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares of the company's stock, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 5,146 shares of company stock worth $3,262,847 over the last ninety days. 6.10% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the company. Morgan Stanley raised Axon Enterprise from an "equal weight" rating to an "overweight" rating and raised their target price for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. Barclays set a $726.00 price objective on shares of Axon Enterprise and gave the company an "overweight" rating in a research note on Thursday, February 27th. Craig Hallum downgraded shares of Axon Enterprise from a "buy" rating to a "hold" rating and set a $625.00 price objective on the stock. in a report on Thursday, February 20th. The Goldman Sachs Group increased their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a report on Monday, January 27th. Finally, JMP Securities reissued an "outperform" rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Three research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $587.38.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.